Andrew N. Schiff is Director at Aclaris Therapeutics, Inc. (ACRS). They have made 17 open-market trades across 8 companies since 2013, most recently 2026-06-05.
CIK 0001172252
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $25.7M since 2013, against 12 sales. Across 5 scored buys the stock is down 4.5% at ninety days, and 5.7 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 40% | 40% |
| Avg Move | -19.5% | -1.9% | -4.5% |
| Alpha | -14.7% | -2.4% | -5.7% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACRS | SELL | 2022-11-10 | 2022-11-14 | $17.05 | $1.8M | -1.6% | -9.3% | -24.1% |
| ACRS | SELL | 2022-10-24 | 2022-10-26 | $17.01 | $1.4M | -5.6% | +6.4% | -0.4% |
| ACRS | SELL | 2022-10-17 | 2022-10-19 | $16.57 | $1.7M | -2.4% | +14.8% | +11.9% |
| ACRS | SELL | 2022-10-07 | 2022-10-11 | $16.16 | $237K | +9.4% | +11.8% | +7.6% |
| ACRS | SELL | 2022-10-04 | 2022-10-06 | $16.45 | $1.5M | +3.5% | -5.4% | -8.8% |
| ACRS | SELL | 2022-06-17 | 2022-06-21 | $15.14 | $592K | -11.8% | +1.4% | -11.4% |
| LOXO | SELL | 2018-07-10 | 2018-07-12 | $179.43 | $251.2M | -6.3% | -11.4% | -9.3% |
| ACRS | BUY | 2017-08-16 | 2017-08-16 | $23.02 | $5.0M | -10.1% | -5.0% | -18.1% |
| ZLTQ | SELL | 2016-08-11 | 2016-08-12 | $36.39 | $18.2M | -1.8% | +0.6% | +5.1% |
| ZLTQ | SELL | 2016-08-11 | 2016-08-12 | $36.39 | $36.4M | -1.8% | +0.6% | +5.1% |
| ZLTQ | SELL · 10b5-1 | 2015-12-07 | 2015-12-09 | $30.13 | $988K | -5.5% | -6.8% | -17.5% |
| ZLTQ | SELL | 2015-11-20 | 2015-11-24 | $30.73 | $7.9M | -5.5% | -0.8% | -22.3% |
| ZLTQ | SELL | 2015-11-18 | 2015-11-20 | $30.77 | $7.5M | -5.5% | -0.8% | -27.6% |
| TTOO | BUY | 2014-08-12 | 2014-08-14 | $11.00 | $5.0M | -22.2% | +2.3% | +2.3% |
| AGRX | BUY | 2014-05-23 | 2014-05-28 | $6.00 | $8.0M | -16.6% | +0.2% | +0.2% |
| TRXC | BUY | 2014-04-21 | 2014-04-23 | $4.00 | $4.2M | -28.3% | -5.7% | -5.7% |
| DRTX | SELL | 2014-03-20 | 2014-03-21 | $15.74 | $1.6M | N/A | N/A | N/A |
| ADMA | BUY | 2013-10-22 | 2013-10-23 | $8.50 | $3.5M | -20.4% | -1.5% | -1.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| DRTX | 3,032,824 | — |
| TRXC.OB | 36,490,260 | — |
| Total | $642.8M |
Shares reported on the most recent Form 4, priced at the 2026-06-08 close. 2 holdings could not be priced and are excluded from the total.